Pomerantz LLP has filed a class action lawsuit against Tenax Therapeutics and certain officers for allegedly making false and misleading statements about the effectiveness of their drug TNX-103 during clinical trials. The lawsuit covers investors who bought Tenax securities between November 2023 and August 2026, following the company's failure to meet primary endpoints in its Phase 3 clinical trial announced in August 2026, which caused the stock price to plummet nearly 90%. The suit claims Tenax overstated the drug's clinical and commercial prospects, violating federal securities laws. Investors have until December 28, 2026, to join the class action or seek lead plaintiff status.
The class action lawsuit against Tenax Therapeutics and certain officers comes amid a health sector where, as of Oct 28, 2026 03:11 WIB, 88 of 150 priced US health stocks on Pluang rose while 62 fell. Notable movers include ClearPoint Neuro Inc (CLPT) with a price of USD 9.67 and a 1-day change of +6.97%, Novavax Inc (NVAX) at USD 10.03 with +6.70%, and Spyre Therapeutics Inc. (SYRE) at USD 98.88 with +6.43%. Typical hold times on Pluang range from 3 to 59 days for these stocks, with order activity showing strong buying interest for CLPT and NVAX.
Vallourec will publish its Q3 2026 financial results on November 20, 2026, at 07:30 AM CET. The company's CEO Philippe Guillemot and CFO Nathalie Delbreuve will present the results via a conference call and webcast at 09:30 AM CET the same day. Inves...
MyPropCapital Technology Limited has launched a new trading evaluation platform that uses the Arbitrum One blockchain to record all fees, rules, passes, and rewards publicly. This system allows traders to verify every detail of their trading deals wi...
The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026 following its Supervisory Review and Evaluation Process (SREP). KBC must maintain a fully loaded CET1 ratio of 10.94%, which includes various regulatory b...
Bitget Wallet introduced Virtual Account, allowing users to open free USD and EUR accounts within their self-custodial crypto wallet, powered by licensed partner Noah. Funds deposited convert automatically to stablecoins like USDT or USDC, usable for...
The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026, maintaining the Pillar 2 Requirement at 1.95% and Pillar 2 Guidance at 1.00%. This results in an overall CET1 capital requirement of 10.94%. As of Q2 202...
